Advanced Medicine in China

New drug and technology consultation and treatment and go to China to receive anticancer therapies such as CAR-T, TILs, and cancer vaccines.

[Advanced Medicine in China @Advanced_Medici]

Why Are More and More International Patients Coming to China for CAR-T Cell Therapy?

#CARTtherapy #InternationalPatient #CART #Multiplemyeloma #lymphoma #Leukemia #HealthJourney

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/Xon25uwfln

[Advanced Medicine in China @Advanced_Medici]

#PatientStory: CAR-T Therapy Brings New Hope for #Lymphoma Patients – A Case from a Chinese Hospital

#CART #CARTtherapy #PatientSuccess #Oncology #HopeForCancer

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/y1zjs6zBwn

[Advanced Medicine in China @Advanced_Medici]

China’s CAR-T Therapy Emerging in Glioma Treatment: Neurosurgery Team Wins Three International Awards

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

#CART #Glioma #Neurosurgery #CARTTherapy #ChinasCART #solidtumor #IENA2024

→https://t.co/ETYofczLn5

[Advanced Medicine in China @Advanced_Medici]

Exceptional Efficacy of CAR-T Therapy in China: Disease Control Rate for Advanced Liver Cancer Reaches 78% to 91.3%

#CARTTherapy #LiverCancer #SolidTumors #CancerTreatment #CART

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/JDTRnQ2KR0

[Advanced Medicine in China @Advanced_Medici]

New Breakthrough in CAR-T Cell Research in China: Type 2 T Cell Function Supports Long-term Leukemia Remission

#CART #Leukemia #Type2TCells #ALL #GATA3

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/h7GEGTe0FF

[Advanced Medicine in China @Advanced_Medici]

#APBMT 2024丨Global Breakthrough of Chinese #CART Therapy: New Advances in the Treatment of Central Nervous System #Lymphoma (#CNSL)

#APBMT2024 #CentralNervousSystemLymphoma

WhatsApp: https://t.co/qEUY5J6Ztz: [email protected]

→https://t.co/8NsQi5kPcK

[Advanced Medicine in China @Advanced_Medici]

#PatientStory | Chinese CAR-T Therapy: An Inspiring Journey of Changing Fate for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma #RRDLBCL

#CART #DLBCL

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/Vn0POD0VJ2

[Advanced Medicine in China @Advanced_Medici]

The World’s First! China’s Non-Viral Site-Specific Integrated PD1-CAR-T Therapy Brings New Hope for Systemic Lupus Erythematosus(SLE) Patients

#PD1 #CART #SLE #Lupus #CARTTherapy

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/zSPsMfXAqk

[Advanced Medicine in China @Advanced_Medici]

Groundbreaking Chinese CAR-T Research: CD5 CAR-T Therapy Brings New Hope for Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL)

#CART #ALL #CARTtherapy #leukemia #Tcell

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]
→https://t.co/Sz7p4FXuqN

[Advanced Medicine in China @Advanced_Medici]

Breakthrough in China’s CAR-T Therapy for Treating Relapsed B-ALL: Donor-Derived CD19 CAR-T Shows Long-Term Survival Advantage

#CAR_TTherapy #B_ALL #CAR_T #ALL #ChinaCART #CD19

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/bMG6TehHSx

[Advanced Medicine in China @Advanced_Medici]

The Rise of China’s CAR-T Therapy: New Hope for Multiple Myeloma Patients

#CARTTherapy #CART #MultipleMyeloma #BloodCancer #patientstory #ChinaCART #CARTTherapy

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/8SLbyMjbht

[Advanced Medicine in China @Advanced_Medici]

New Advances in Chinese CAR-T Cell Therapy: CD27 Armored BCMA CAR-T Shows Potential in Treating Relapsed Multiple Myeloma

#BCMA #CD27 #RRMM #MM #MultipleMyeloma #CART

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/T7PUkyx8JQ

[Advanced Medicine in China @Advanced_Medici]

China Overcomes Solid Tumor Challenge: CAR-T Technology IM96 Leads Innovation in Colorectal Cancer Treatment

#IM96 #CART #ColorectalCancer #CARTtherapy #ESMO #2024ASCO #SolidTumor

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/F7iBJhud7O

[Advanced Medicine in China @Advanced_Medici]

CAR-T Cell Therapy as a New Option for Treating Multiple Myeloma

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

#MultipleMyeloma #CAR_TCellTherapy #CancerTreatment #Immunotherapy #Hematology #CellTherapy #PatientCare #Oncology

→https://t.co/3UQJMISmCa

[Advanced Medicine in China @Advanced_Medici]

China’s CAR-T Therapy: A Beacon of Hope for Children with Acute Lymphoblastic Leukemia (ALL)

#CARTTherapy #Leukemia #ALL #CART #AcuteLymphoblasticLeukemia #Patientstory

WhatsApp: https://t.co/dtxbgkm9ka
Email: [email protected]

→https://t.co/kbo7tcCgUC

[Advanced Medicine in China @Advanced_Medici]

China’s CAR-T Therapy as a Beacon of Hope: A New Light for Multiple Myeloma Patients

#CARTTherapy #MultipleMyeloma #PatientStory #CancerSurvivor #CancerTreatment #Immunotherapy

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/QF4mKKJyhW

[Advanced Medicine in China @Advanced_Medici]

China’s CSPC Pharmaceutical Group CAR-T Therapy: Targeted Treatment for Myasthenia Gravis

#CARTTherapy #MyastheniaGravis #ChinaPharma #CSPC #CART #Immunotherapy #ClinicalApproval

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/iXTYa6rdoZ

[Advanced Medicine in China @Advanced_Medici]

China’s New CAR-T Therapy: Bringing New Hope for Acute Myeloid Leukemia (AML)

#CLL1CART #AML #Leukemia #CART #CARTtherapy #AcuteMyeloidLeukemia #CLL1 #CD371

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/ztP54K8mRh

[Advanced Medicine in China @Advanced_Medici]

Beacon of Hope: China’s CAR-T Therapy Helps a TP53-Deficient Diffuse Large B-Cell Lymphoma(#DLBCL) Patient Achieve Complete Remission

#CART #Lymphoma #TP53

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/Q4OxCAUrlz

[Advanced Medicine in China @Advanced_Medici]

Chinese Scientists Achieve Major Breakthrough in Enhancing CAR-T Cell Efficacy: MEK Inhibitors Effectively Prevent CAR-T Cell Exhaustion

#CARTCellTherapy #MEKInhibitors #CART #MEK

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/PYmKjVRsq2

[Advanced Medicine in China @Advanced_Medici]

Significant Progress in CAR-T Therapy in China: Long-Term Effects of Combined CD19 and CD22 Treatment for Acute B-Lymphoblastic Leukemia

#ALL #Leukemia #B_ALL #LeukemiaTreatment

WhatsApp: https://t.co/wjmfIYSqvq
Email: [email protected]

→https://t.co/yQtSaXHy5F